Guinea vs Syrian Arab Republic: Previously treated cases tested for RR-/MDR-TB
Guinea
29.0%
in 2024
Syrian Arab Republic
32.0%
in 2024
Guinea rank
161st
Syrian Arab Republic rank
160th
Previously treated cases tested for RR-/MDR-TB over time
- Guinea
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 32.0% against 29.0% in Guinea, a difference of 3.0%.
That makes Syrian Arab Republic's figure about 1.1 times Guinea's.
The two have swapped places 7 times across 19 shared years of data; in 2005 it was Guinea ahead.
Guinea ranks 161st and Syrian Arab Republic ranks 160th of 180 countries.
Syrian Arab Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.9% | 7.0% | 1.1% | Syrian Arab Republic |
| 2010s | 45.9% | 52.5% | 6.6% | Syrian Arab Republic |
| 2020s | 70.8% | 86.4% | 15.6% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Guinea or Syrian Arab Republic?
- Syrian Arab Republic, at 32.0% against 29.0% in Guinea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Guinea and Syrian Arab Republic?
- 3.0%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Guinea and Syrian Arab Republic?
- 19 years are reported by both, from 2005 to 2024.
- How do Guinea and Syrian Arab Republic rank globally for previously treated cases tested for rr-/mdr-tb?
- Guinea ranks 161st and Syrian Arab Republic ranks 160th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.